1 |
A-623 or amg 623 |
- |
- |
- |
- |
066 1件: 66 💬 |
2 |
A07ea06 |
- |
- |
- |
- |
066 1件: 66 💬 |
3 |
Abelmoschus manihot |
- |
- |
- |
- |
066 1件: 66 💬 |
4 |
Ace inhibitor |
- |
- |
- |
- |
066 1件: 66 💬 |
5 |
Ace inhibitor + statin |
- |
- |
- |
- |
066 1件: 66 💬 |
6 |
Ace inhibitor or angiotensin receptor antagonist |
Angiotensin II |
2件: D00150 D00150, D02014 D02014 💬 |
AGTR1 2件: AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
7 |
Ace/arb |
- |
- |
- |
- |
066 1件: 66 💬 |
8 |
Acei |
- |
- |
- |
- |
066 2件: 66, 224 💬 |
9 |
Acei/arb and corticosteroids |
- |
- |
- |
- |
066 1件: 66 💬 |
10 |
Acteoside |
Acteoside |
- |
- |
- |
066 1件: 66 💬 |
11 |
Acth |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 5件: 13, 66, 145, 193, 222 💬 |
12 |
Acth (acthar) gel |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
066 1件: 66 💬 |
13 |
Acthar |
- |
- |
- |
- |
002 9件: 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
14 |
Acthar 80 unit injection |
- |
- |
- |
- |
066 1件: 66 💬 |
15 |
Aliskiren |
Aliskiren |
1件: D03208 D03208 💬 |
REN 1件: REN 💬 |
Diabetic cardiomyopathy 3件: Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system |
066 4件: 66, 167, 222, 223 💬 |
16 |
Allopurinol |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 6件: 6 , 46, 57, 66, 96, 97 💬 |
17 |
Aln-cc5 |
- |
- |
- |
- |
062 3件: 62, 66, 109 💬 |
18 |
Angiotensin |
Angiotensin II |
2件: D00150 D00150, D02014 D02014 💬 |
AGTR1 2件: AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 7件: 17, 19, 46, 66, 86, 222, 224 💬 |
19 |
Angiotensin blockade |
Angiotensin II |
2件: D00150 D00150, D02014 D02014 💬 |
AGTR1 2件: AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
20 |
Angiotensin ii |
Angiotensin II |
2件: D00150 D00150, D02014 D02014 💬 |
AGTR1 2件: AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 2件: 66, 222 💬 |
21 |
Apl-2 |
- |
- |
- |
- |
061 5件: 61, 62, 66, 222, 223 💬 |
22 |
Arb |
- |
- |
- |
- |
066 1件: 66 💬 |
23 |
Artesunate |
Artesunate |
1件: D02482 D02482 💬 |
- |
- |
066 1件: 66 💬 |
24 |
Atacicept |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 49, 66 💬 |
25 |
Atacicept 25 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 2件: 13, 66 💬 |
26 |
Atacicept 75 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 3件: 13, 49, 66 💬 |
27 |
Atacicept150mg |
- |
- |
- |
- |
066 1件: 66 💬 |
28 |
Atacicept25mg |
- |
- |
- |
- |
066 1件: 66 💬 |
29 |
Atacicept75mg |
- |
- |
- |
- |
066 1件: 66 💬 |
30 |
Atg-f |
- |
- |
- |
- |
066 1件: 66 💬 |
31 |
Atrasentan |
Atrasentan |
- |
- |
- |
066 3件: 66, 218, 222 💬 |
32 |
Avb-s6-500 |
- |
- |
- |
- |
066 1件: 66 💬 |
33 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
34 |
Bardoxolone |
Bardoxolone |
1件: D09584 D09584 💬 |
- |
- |
066 7件: 66, 67, 84, 85, 86, 218, 222 💬 |
35 |
Bardoxolone methyl |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
066 7件: 66, 67, 84, 85, 86, 218, 222 💬 |
36 |
Bardoxolone methyl capsules |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
066 4件: 66, 67, 86, 222 💬 |
37 |
Belimumab |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 10件: 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬 |
38 |
Benlysta |
- |
- |
- |
- |
043 5件: 43, 49, 53, 66, 222 💬 |
39 |
Benlysta® (belimumab) |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 3件: 11, 66, 222 💬 |
40 |
Bion-1301 multiple doses |
- |
- |
- |
- |
066 1件: 66 💬 |
41 |
Bion-1301 single dose |
- |
- |
- |
- |
066 1件: 66 💬 |
42 |
Blisibimod |
Blisibimod |
1件: D10311 D10311 💬 |
- |
- |
043 5件: 43, 44, 49, 63, 66 💬 |
43 |
Blisibimod injection |
Blisibimod |
1件: D10311 D10311 💬 |
- |
- |
066 1件: 66 💬 |
44 |
Blood sample |
- |
- |
- |
- |
008 13件: 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
45 |
Bortezomib |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
46 |
Bortezomib (velcade®) |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
066 1件: 66 💬 |
47 |
Budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
48 |
Calcitriol |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 8件: 37, 46, 49, 66, 96, 158, 235, 326 💬 |
49 |
Ccx168 |
- |
- |
- |
- |
043 6件: 43, 44, 66, 109, 222, 223 💬 |
50 |
Cemdisiran |
Cemdisiran |
- |
- |
- |
066 2件: 66, 109 💬 |
51 |
Chinese herb prescription granule plus prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
52 |
Cilazapril |
Cilazapril |
2件: D01069 D01069, D07699 D07699 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
066 1件: 66 💬 |
53 |
Corticosteroid |
- |
- |
- |
- |
013 10件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
54 |
Corticotherapy |
- |
- |
- |
- |
066 1件: 66 💬 |
55 |
Cyclophosphamid |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
066 1件: 66 💬 |
56 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
57 |
Decortin h |
- |
- |
- |
- |
066 3件: 66, 97, 145 💬 |
58 |
Dipyridamole |
Dipyridamole |
1件: D00302 D00302 💬 |
PDE4A 2件: PDE4A, PDE5A 💬 |
Metabolic pathways 6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 5件: 46, 49, 51, 66, 224 💬 |
59 |
Enalapril |
Enalapril |
2件: D00621 D00621, D07892 D07892 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 7件: 19, 46, 66, 113, 210, 222, 223 💬 |
60 |
Enalapril valsartan methylprednisone |
Enalapril |
3件: D00400 D00400, D00621 D00621, D07892 D07892 💬 |
ACE 2件: ACE, AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
61 |
Fecal microbiota transplantation |
- |
- |
- |
- |
002 5件: 2 , 66, 94, 96, 97 💬 |
62 |
Fish oil |
Fish oil |
- |
- |
- |
013 7件: 13, 46, 49, 66, 96, 260, 299 💬 |
63 |
Fos |
- |
- |
- |
- |
066 2件: 66, 96 💬 |
64 |
Fostamatinib |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
046 4件: 46, 49, 61, 66 💬 |
65 |
Fostamatinib 100 mg |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 1件: 66 💬 |
66 |
Fostamatinib 100 mg tablet |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 1件: 66 💬 |
67 |
Fostamatinib 150 mg |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 1件: 66 💬 |
68 |
Fostamatinib 150 mg tablet |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 1件: 66 💬 |
69 |
Fostamatinib disodium |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
046 3件: 46, 61, 66 💬 |
70 |
Fostamatinib disodium tablet 100 mg |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 1件: 66 💬 |
71 |
Fostamatinib disodium tablet 150 mg |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 1件: 66 💬 |
72 |
Gastrus |
- |
- |
- |
- |
066 1件: 66 💬 |
73 |
Gsk1550188 |
- |
- |
- |
- |
011 4件: 11, 49, 66, 222 💬 |
74 |
High dose-vis649 |
- |
- |
- |
- |
066 1件: 66 💬 |
75 |
Hormone (prednisone) |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
76 |
Human soluble recombinant fc-gamma receptor iib |
- |
- |
- |
- |
066 1件: 66 💬 |
77 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
78 |
Hydroxychloroquine sulfate |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
046 2件: 46, 66 💬 |
79 |
Immunosuppressants |
- |
- |
- |
- |
066 1件: 66 💬 |
80 |
Immunosuppressive treatment |
- |
- |
- |
- |
066 1件: 66 💬 |
81 |
Infusion of adr-001 (mesenchymal stem cell) |
- |
- |
- |
- |
066 1件: 66 💬 |
82 |
Inhibace/cozaar |
- |
- |
- |
- |
066 1件: 66 💬 |
83 |
Intervention for incipient patients at low risk of disease progression |
- |
- |
- |
- |
066 1件: 66 💬 |
84 |
Intervention for patients at high risk of disease progression |
- |
- |
- |
- |
066 1件: 66 💬 |
85 |
Intravenous rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
066 1件: 66 💬 |
86 |
Ionis-fb-lrx |
- |
- |
- |
- |
066 1件: 66 💬 |
87 |
Iptacopan |
Iptacopan |
- |
- |
- |
066 1件: 66 💬 |
88 |
Irbesartan |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 4件: 66, 167, 168, 222 💬 |
89 |
Irbesartan approved in the netherlands |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
90 |
Irbesartan tablets |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 2件: 66, 222 💬 |
91 |
Irbesartan tablets (approved in the usa. reference listed drug avapro) ndc # 43547-0374-03 |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 2件: 66, 222 💬 |
92 |
Irbesartan tablets (ndc# 0955-1041-90 approved in the usa) |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
93 |
Irbesartan tablets (ndc# 43547-375-50 approved in the usa) generic tablets distributed by solco healthcare us, llc |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
94 |
Leflunomide |
Leflunomide |
1件: D00749 D00749 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
011 10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 💬 |
95 |
Leflunomide 20 mg+prednisone 0.5mg/kg/d |
Leflunomide |
2件: D00473 D00473, D00749 D00749 💬 |
DHODH 2件: DHODH, NR3C1 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism |
066 1件: 66 💬 |
96 |
Lisinopril |
Lisinopril |
2件: D00362 D00362, D08131 D08131 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 7件: 19, 46, 49, 66, 67, 113, 222 💬 |
97 |
Lnp023 |
- |
- |
- |
- |
062 3件: 62, 66, 222 💬 |
98 |
Losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
99 |
Low antigen content diet |
- |
- |
- |
- |
066 1件: 66 💬 |
100 |
Low dose-vis649 |
- |
- |
- |
- |
066 1件: 66 💬 |
101 |
Medium dose-vis649 |
- |
- |
- |
- |
066 1件: 66 💬 |
102 |
Menatetrenone |
Menatetrenone |
1件: D00100 D00100 💬 |
- |
- |
066 1件: 66 💬 |
103 |
Methylprednisolon |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 4件: 13, 14, 51, 66 💬 |
104 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
105 |
Methylprednisolone (mp) or prednisone (pred) |
Methylprednisolone |
7件: D00407 D00407, D00473 D00473, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
106 |
Methylprednisolone mylan générique |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
107 |
Methylprednisolone pulse |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 2件: 66, 220 💬 |
108 |
Methylprednisolone(intravenously in the 1st-2nd-3rd month ) |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
109 |
Methylprednisolone(intravenously in the 1st-3rd-5th month) |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
110 |
Methylprednisone |
Methylprednisone |
- |
- |
- |
046 3件: 46, 66, 222 💬 |
111 |
Mizoribine |
Mizoribine |
1件: D01392 D01392 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
046 8件: 46, 49, 51, 53, 66, 94, 222, 224 💬 |
112 |
Mmf |
- |
- |
- |
- |
013 13件: 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬 |
113 |
Multi-glycoside of tripterygium wilfordii hook. f. (twh) |
Tripterygium wilfordii whole |
- |
- |
- |
066 1件: 66 💬 |
114 |
Mycophenolat-natrium |
- |
- |
- |
- |
066 1件: 66 💬 |
115 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
116 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
117 |
Mycophenolate mofetil (mmf) |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
013 7件: 13, 49, 51, 60, 65, 66, 222 💬 |
118 |
Mycophenolate mofetil plus lower dose of prednisone |
Mycophenolate mofetil |
5件: D00473 D00473, D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 3件: IMPDH1, IMPDH2, NR3C1 💬 |
Drug metabolism - other enzymes 4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism |
066 1件: 66 💬 |
119 |
Mycophenolate sodium |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
053 3件: 53, 66, 222 💬 |
120 |
Mycophenolic acid |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 8件: 11, 43, 49, 51, 60, 66, 96, 222 💬 |
121 |
Mycophenolic sodium |
- |
- |
- |
- |
066 2件: 66, 222 💬 |
122 |
Myfortic |
- |
- |
- |
- |
049 5件: 49, 66, 162, 222, 228 💬 |
123 |
Myfortic 180mg tablets |
- |
- |
- |
- |
066 2件: 66, 222 💬 |
124 |
Myfortic 360mg tablets |
- |
- |
- |
- |
066 2件: 66, 222 💬 |
125 |
Narsoplimab |
Narsoplimab |
1件: D11531 D11531 💬 |
MASP2 1件: MASP2 💬 |
Complement and coagulation cascades 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
066 3件: 66, 222, 223 💬 |
126 |
Nefecon |
- |
- |
- |
- |
066 1件: 66 💬 |
127 |
Omega-3 |
Omega-3 fatty acids |
- |
- |
- |
013 7件: 13, 46, 49, 66, 79, 96, 299 💬 |
128 |
Omega-3 fatty acid |
Omega-3 fatty acids |
- |
- |
- |
046 2件: 46, 66 💬 |
129 |
Omega-3 fatty acid ethylester90 |
Omega-3 fatty acids |
- |
- |
- |
066 1件: 66 💬 |
130 |
Omega-3 fatty acid fish oil supplement |
Fish oil |
- |
- |
- |
066 1件: 66 💬 |
131 |
Oms721 |
- |
- |
- |
- |
064 3件: 64, 66, 109 💬 |
132 |
Oms721 (narsoplimab) |
Narsoplimab |
1件: D11531 D11531 💬 |
MASP2 1件: MASP2 💬 |
Complement and coagulation cascades 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
066 3件: 66, 222, 223 💬 |
133 |
Opl-ccl2-lpm |
- |
- |
- |
- |
066 1件: 66 💬 |
134 |
Other: continue their usual therapy |
- |
- |
- |
- |
066 1件: 66 💬 |
135 |
Other: intensive supportive care |
- |
- |
- |
- |
066 1件: 66 💬 |
136 |
Other: optimized supportive care |
- |
- |
- |
- |
066 1件: 66 💬 |
137 |
Other: vehicle (d5w or saline) |
- |
- |
- |
- |
066 1件: 66 💬 |
138 |
Over-encapsulated 150 mg irbesartan tablets |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
139 |
Over-encapsulated irbesartan |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
140 |
Over-encapsulated irbesartan tablets |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 2件: 66, 222 💬 |
141 |
Paricalcitol |
Paricalcitol |
1件: D00930 D00930 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
019 3件: 19, 66, 218 💬 |
142 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
143 |
Potassium |
Potassium |
1件: D08403 D08403 💬 |
- |
- |
036 10件: 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
144 |
Prednisolon |
- |
- |
- |
- |
046 6件: 46, 50, 51, 66, 96, 97 💬 |
145 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
146 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
147 |
Prednisone + inhibace/cozaar |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
148 |
Prednisone 5 mg |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 2件: 46, 66 💬 |
149 |
Prednisone alone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 2件: 11, 66 💬 |
150 |
Prednisone and cyclophosphamide |
Cyclophosphamide |
3件: D00287 D00287, D00473 D00473, D07760 D07760 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
151 |
Prednisone arrow 20mg |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
152 |
Prednisone arrow 5 mg |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
153 |
Prednisone in full dose |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
154 |
Prednisone or prednisolone |
Prednisolone |
9件: D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
155 |
Prednisone plus cyclophosphamide |
Cyclophosphamide |
3件: D00287 D00287, D00473 D00473, D07760 D07760 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
156 |
Probucol |
Probucol |
1件: D00476 D00476 💬 |
- |
- |
066 1件: 66 💬 |
157 |
Procedure: plasma exchange (pe) |
- |
- |
- |
- |
066 2件: 66, 220 💬 |
158 |
Protectis |
- |
- |
- |
- |
066 1件: 66 💬 |
159 |
R935788 |
- |
- |
- |
- |
046 3件: 46, 61, 66 💬 |
160 |
Ramipril |
Ramipril |
1件: D00421 D00421 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 7件: 46, 49, 66, 67, 113, 218, 257 💬 |
161 |
Rapamune |
- |
- |
- |
- |
002 8件: 2 , 60, 66, 67, 84, 158, 278, 280 💬 |
162 |
Ras |
- |
- |
- |
- |
006 3件: 6 , 13, 66 💬 |
163 |
Ras 2410 |
- |
- |
- |
- |
066 1件: 66 💬 |
164 |
Rc18 160mg |
- |
- |
- |
- |
011 3件: 11, 13, 66 💬 |
165 |
Rc18 240mg |
- |
- |
- |
- |
013 2件: 13, 66 💬 |
166 |
Re-021 |
- |
- |
- |
- |
066 2件: 66, 222 💬 |
167 |
Reh-acteoside |
Acteoside |
- |
- |
- |
066 1件: 66 💬 |
168 |
Renin angiotensin system (ras) blockade |
Angiotensin II |
2件: D00150 D00150, D02014 D02014 💬 |
AGTR1 2件: AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
169 |
Risedronate |
Risedronic acid |
3件: D00942 D00942, D03234 D03234, D08484 D08484 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 6件: 46, 50, 66, 96, 113, 274 💬 |
170 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
171 |
Simulect |
- |
- |
- |
- |
066 2件: 66, 97 💬 |
172 |
Simvastatin |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 21件: 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
173 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
174 |
Sirolimus (study drug)+ace inhibitor + statin |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
066 1件: 66 💬 |
175 |
Sm101 |
- |
- |
- |
- |
049 3件: 49, 63, 66 💬 |
176 |
Sparsentan |
Sparsentan |
1件: D11776 D11776 💬 |
AGTR1 2件: AGTR1, EDNRA 💬 |
AGE-RAGE signaling pathway in diabetic complications 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
066 2件: 66, 222 💬 |
177 |
Sparsentan tablets |
Sparsentan |
1件: D11776 D11776 💬 |
AGTR1 2件: AGTR1, EDNRA 💬 |
AGE-RAGE signaling pathway in diabetic complications 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
178 |
Sparsentan tablets/ over-encapsulated sparsentan tablets |
Sparsentan |
1件: D11776 D11776 💬 |
AGTR1 2件: AGTR1, EDNRA 💬 |
AGE-RAGE signaling pathway in diabetic complications 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
179 |
Sparsentan tablets/over-encapsulated sparsentan tablets |
Sparsentan |
1件: D11776 D11776 💬 |
AGTR1 2件: AGTR1, EDNRA 💬 |
AGE-RAGE signaling pathway in diabetic complications 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
180 |
Sparsentan tablets/overencapsulated sparsentan tablets |
Sparsentan |
1件: D11776 D11776 💬 |
AGTR1 2件: AGTR1, EDNRA 💬 |
AGE-RAGE signaling pathway in diabetic complications 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
066 1件: 66 💬 |
181 |
Steroids |
- |
- |
- |
- |
046 7件: 46, 50, 51, 63, 66, 96, 97 💬 |
182 |
Steroids plus azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
066 1件: 66 💬 |
183 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
184 |
Supportive and immunosuppressive therapy |
- |
- |
- |
- |
066 1件: 66 💬 |
185 |
Supportive therapy |
- |
- |
- |
- |
066 1件: 66 💬 |
186 |
Supportive therapy with: ace-inhibitor / arb / statin |
- |
- |
- |
- |
066 1件: 66 💬 |
187 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
188 |
Tailored diet |
- |
- |
- |
- |
066 1件: 66 💬 |
189 |
Telmisartan |
Telmisartan |
1件: D00627 D00627 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 2件: 66, 67 💬 |
190 |
The yi-qi-qing-jie herbal compound |
- |
- |
- |
- |
066 1件: 66 💬 |
191 |
Tripterygium |
Tripterygium wilfordii whole |
- |
- |
- |
046 8件: 46, 66, 67, 96, 162, 222, 224, 271 💬 |
192 |
Tripterygium wilfordii |
Tripterygium wilfordii whole |
- |
- |
- |
046 6件: 46, 66, 67, 222, 224, 271 💬 |
193 |
Tripterygium wilfordii (tw) |
Tripterygium wilfordii whole |
- |
- |
- |
066 2件: 66, 222 💬 |
194 |
Valsartan |
Valsartan |
1件: D00400 D00400 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 7件: 57, 58, 66, 75, 218, 222, 224 💬 |
195 |
Vis649 |
- |
- |
- |
- |
066 1件: 66 💬 |
196 |
Warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
197 |
Wm (shentong granules) |
- |
- |
- |
- |
066 1件: 66 💬 |
198 |
lnp023 hydrochloride salt |
- |
- |
- |
- |
062 3件: 62, 66, 222 💬 |